FridayOL

SAN FRANCISCO, CA – August 19, 2025 – Jaguar Health, Inc. (NASDAQ: JAGX) today announced the successful outcome of its Annual Meeting of Stockholders, with all proposals receiving approval. This milestone marks a significant step forward for the company and reinforces investor confidence in its strategic direction.

The Annual Meeting, held today, saw shareholders overwhelmingly support key initiatives crucial to Jaguar Health's ongoing operations and future growth plans. Details regarding the specific proposals and voting results are available in the company's filings with the Securities and Exchange Commission (SEC).

What Does This Mean for Jaguar Health?

The approval of these proposals provides Jaguar Health with the flexibility and resources needed to execute its business strategy effectively. This includes continued investment in research and development, strategic partnerships, and expansion of its product portfolio. Specifically, shareholder support enables the company to:

• Advance Product Pipeline: Resources can be further allocated to the development and commercialization of innovative therapies, particularly in areas with unmet medical needs.
• Strengthen Financial Position: The approvals allow for optimized capital management, supporting ongoing operations and future investments.
• Foster Strategic Growth: The company can pursue strategic partnerships and collaborations that enhance its market reach and product offerings.

Looking Ahead: Jaguar Health's Vision

Jaguar Health is committed to delivering high-quality, innovative healthcare solutions. The company's focus remains on addressing critical needs in areas like gastrointestinal health and other specialized therapeutic categories. This recent success at the Annual Meeting underscores the company's dedication to its mission and its ability to adapt and thrive in a dynamic market.

“We are incredibly grateful for the continued support of our shareholders,” said [Insert CEO/Relevant Spokesperson Quote Here - e.g., a brief statement expressing gratitude and outlining future plans]. “These approvals empower us to move forward with confidence and execute our strategic vision for long-term sustainable growth.”

Investors and stakeholders are encouraged to review Jaguar Health’s latest SEC filings and company announcements for more detailed information. The company remains committed to transparency and open communication with its shareholders.

About Jaguar Health, Inc.

Jaguar Health, Inc. is a commercial-stage pharmaceutical company focused on acquiring, licensing, and developing innovative products that address unmet medical needs. The company’s portfolio includes [Mention key products/areas of focus]. For more information, visit [Company Website URL].